Riley S. Ferguson

Riley S. Ferguson

Auto-generated profile, based on publicly available information

Riley S. Ferguson

Department of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, Illinois, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2018 in Chemical Physics Letters
Verified
Journal Article
Closed access
OKOleg Kovtun
Oleg Kovtun
ITIan D. Tomlinson
Ian D. Tomlinson
DBDanielle M. Bailey
Danielle M. Bailey
LTLucas B. Thal
Lucas B. Thal
EREmily J. Ross
Emily J. Ross
SRSandra J. Rosenthal
Sandra J. Rosenthal

21 November 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
OKOleg Kovtun
Oleg Kovtun
ITIan D Tomlinson
Ian D Tomlinson
RFRiley S Ferguson
Riley S Ferguson
SRSandra J Rosenthal
Sandra J Rosenthal
The presynaptic dopamine transporter mediates rapid reuptake of synaptic dopamine. Although cell surface DAT trafficking recently emerged as an important component of DAT regulation, it has not been systematically investigated. Here, we apply our single quantum dot (Qdot) tracking approach to monitor DAT plasma membrane dynamics in several heterologous expression cell hosts with nanometer localization accuracy. We demonstrate that Qdot-tagged DAT proteins exhibited highly heterogeneous membrane diffusivity dependent on the local membrane topography. We also show that Qdot-tagged DATs were localized away from the flat membrane regions and were dynamically retained in the membrane protrusions and cell edges for the duration of imaging. Single quantum dot tracking of wildtype DAT and its conformation-defective coding variants (R60A and W63A) revealed a significantly accelerated rate of dysfunctional DAT membrane diffusion. We believe our results warrant an in-depth investigation as to whether compromised membrane dynamics is a common feature of brain disorder-derived DAT mutants.

25 June 2020 in Biochemistry
Verified
Journal Article
Closed access
OKOleg Kovtun
Oleg Kovtun
RTRuben Torres
Ruben Torres
RFRiley S. Ferguson
Riley S. Ferguson
TJTravis Josephs
Travis Josephs
SRSandra J. Rosenthal
Sandra J. Rosenthal

17 June 2023 in Journal of Surgical Education
Verified
Journal Article
Closed access
KWKiersten C. Woodyard
Kiersten C. Woodyard
ELErmina Lee
Ermina Lee
RFRiley Ferguson
Riley Ferguson
DDDouglas Dembinski
Douglas Dembinski
MEMaleeh Effendi
Maleeh Effendi
RGRyan M. Gobble
Ryan M. Gobble

14 July 2026 in The American Journal of Medicine
Verified
Journal Article
Open access
SGSeyyedehfatemeh Ghalibafan
Seyyedehfatemeh Ghalibafan
RFRiley Ferguson
Riley Ferguson
CUClaire Ufongene
Claire Ufongene
ASAmrish Selvam
Amrish Selvam
MSMatthew Saperstein
Matthew Saperstein
ADAli Djalilian
Ali Djalilian
Contact lens wear is common, and patients with related acute red eye often present first in non-ophthalmology settings, including emergency departments, urgent care centers, family medicine practices, and primary care clinics. In these settings, access to slit-lamp examination may be limited, and even when available, accurate interpretation depends on clinician experience. Acute red eye in contact lens users may reflect noninfectious inflammatory disease, but it can also signal early microbial keratitis, which may initially present with subtle or nonspecific findings. Delayed or missed recognition can lead to progressive corneal damage and visual loss. Despite increasing contact lens use and the risk of vision-threatening complications, practical, evidence-based guidance tailored to frontline non-ophthalmologist clinicians remains limited. When bacterial keratitis is suspected and timely ophthalmology evaluation cannot be confirmed, frequent topical fluoroquinolone therapy may be needed because commonly used topical antibiotics may not provide adequate corneal coverage. This review aims to provide clear, practical guidance to improve triage, support timely referral, and prevent avoidable corneal morbidity, particularly in underserved settings where access barriers may worsen outcomes and follow-up.